Bridgefront Capital’s CVS Health CVS Stock Holding History

Bridgefront Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Buy	14,176 +2,947	+26%	+$263K	0.39%	63
2026 Q1	$806K	Sell	11,229 -6,842	-38%	-$527K	0.2%	164
2025 Q4	$1.43M	Buy	+18,071	New	+$1.42M	0.36%	73
2025 Q3	–	Sell	-6,847	Closed	-$472K	–	628
2025 Q2	$472K	Buy	+6,847	New	+$449K	0.13%	292
2025 Q1	–	Sell	-11,644	Closed	-$523K	–	671
2024 Q4	$523K	Buy	+11,644	New	+$653K	0.18%	196
2023 Q2	–	Sell	-23,183	Closed	-$1.72M	–	499
2023 Q1	$1.72M	Buy	23,183 +10,145	+78%	+$851K	1.05%	2
2022 Q4	$1.22M	Buy	13,038 +10,376	+390%	+$1M	0.85%	2
2022 Q3	$254K	Buy	+2,662	New	+$263K	0.26%	175
2021 Q3	–	Sell	-14,761	Closed	-$1.23M	–	414
2021 Q2	$1.23M	Buy	+14,761	New	+$1.21M	0.46%	26

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bridgefront Capital's CVS Position: Q2 2026 in Review

Bridgefront Capital increased its CVS Health (CVS) stake by 26% in Q2 2026, buying an estimated $263K and bringing the position to 14,176 shares worth $1.47M. The position accounts for 0.39% of the portfolio, ranked #63.

Bridgefront Capital first reported a position in CVS in Q2 2021 and has held it in 9 quarters since. The position peaked at $1.72M in Q1 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Bridgefront Capital held 14,176 shares of CVS Health worth $1.47M as of Q2 2026.
Bridgefront Capital bought 2,947 CVS Health shares in Q2 2026, an estimated $263K.
CVS Health made up 0.39% of Bridgefront Capital's portfolio in Q2 2026, its #63 holding.
Bridgefront Capital first reported a position in CVS Health in Q2 2021 and has held it in 9 quarters since.
Bridgefront Capital's CVS Health position peaked at $1.72M in Q1 2023.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.